ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.47B -23.0%
Revenue (ttm)	1.21B +12.0%
Net Income	93.56M -0.7%
EPS	1.97 -1.8%
Shares Out	47.34M
PE Ratio	37.26
Forward PE	n/a
Dividend	0.30 (0.41%)
Ex-Dividend Date	Aug 26, 2026

Volume	34,512
Open	72.40
Previous Close	73.40
Day's Range	72.00 - 73.30
52-Week Range	66.00 - 110.50
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error